Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/43130
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Rincón Arévalo, Héctor Julián | - |
dc.contributor.author | Szelinski, Franziska | - |
dc.contributor.author | Schrezenmeier, Eva | - |
dc.contributor.author | Stefanski, Ana Luisa | - |
dc.contributor.author | Wiedemann, Annika | - |
dc.contributor.author | Weißenberg, Sarah Y. | - |
dc.contributor.author | Welle, Anna | - |
dc.contributor.author | Jungmann, Annemarie | - |
dc.contributor.author | Nordström, Karl | - |
dc.contributor.author | Walter, Jörn | - |
dc.contributor.author | Imgenberg Kreuz, Juliana | - |
dc.contributor.author | Nordmark, Gunnel | - |
dc.contributor.author | Rönnblom, Lars | - |
dc.contributor.author | Rönnblom, Lars | - |
dc.contributor.author | Catalina, Michelle D. | - |
dc.contributor.author | Grammer, Amrie C. | - |
dc.contributor.author | Lipsky, Peter E. | - |
dc.contributor.author | Lino, Andreia C. | - |
dc.contributor.author | Dörner, Thomas | - |
dc.date.accessioned | 2024-11-04T12:42:32Z | - |
dc.date.available | 2024-11-04T12:42:32Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Weißenberg SY, Szelinski F, Schrezenmeier E, Stefanski AL, Wiedemann A, Rincon-Arevalo H, Welle A, Jungmann A, Nordström K, Walter J, Imgenberg-Kreuz J, Nordmark G, Rönnblom L, Bachali P, Catalina MD, Grammer AC, Lipsky PE, Lino AC, Dörner T. Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases. Front Immunol. 2019 Sep 24;10:2136. doi: 10.3389/fimmu.2019.02136. | spa |
dc.identifier.uri | https://hdl.handle.net/10495/43130 | - |
dc.description.abstract | ABSTRACT: Autoimmune diseases (AID) such as systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS), and rheumatoid arthritis (RA) are chronic inflammatory diseases in which abnormalities of B cell function play a central role. Although it is widely accepted that autoimmune B cells are hyperactive in vivo, a full understanding of their functional status in AID has not been delineated. Here, we present a detailed analysis of the functional capabilities of AID B cells and dissect the mechanisms underlying altered B cell function. Upon BCR activation, decreased spleen tyrosine kinase (Syk) and Bruton's tyrosine kinase (Btk) phosphorylation was noted in AID memory B cells combined with constitutive co-localization of CD22 and protein tyrosine phosphatase (PTP) non-receptor type 6 (SHP-1) along with hyporesponsiveness to TLR9 signaling, a Syk-dependent response. Similar BCR hyporesponsiveness was also noted specifically in SLE CD27- B cells together with increased PTP activities and increased transcripts for PTPN2, PTPN11, PTPN22, PTPRC, and PTPRO in SLE B cells. Additional studies revealed that repetitive BCR stimulation of normal B cells can induce BCR hyporesponsiveness and that tissue-resident memory B cells from AID patients also exhibited decreased responsiveness immediately ex vivo, suggesting that the hyporesponsive status can be acquired by repeated exposure to autoantigen(s) in vivo. Functional studies to overcome B cell hyporesponsiveness revealed that CD40 co-stimulation increased BCR signaling, induced proliferation, and downregulated PTP expression (PTPN2, PTPN22, and receptor-type PTPs). The data support the conclusion that hyporesponsiveness of AID and especially SLE B cells results from chronic in vivo stimulation through the BCR without T cell help mediated by CD40-CD154 interaction and is manifested by decreased phosphorylation of BCR-related proximal signaling molecules and increased PTPs. The hyporesponsiveness of AID B cells is similar to a form of functional anergy. | spa |
dc.format.extent | 16 páginas | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | Frontiers Research Foundation | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by/2.5/co/ | * |
dc.title | Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases | spa |
dc.type | info:eu-repo/semantics/article | spa |
dc.publisher.group | Grupo de Inmunología Celular e Inmunogenética | spa |
dc.identifier.doi | 10.3389/fimmu.2019.02136. | - |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 1664-3224 | - |
oaire.citationtitle | Frontiers in Immunology | spa |
oaire.citationstartpage | 1 | spa |
oaire.citationendpage | 16 | spa |
oaire.citationvolume | 10 | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by/4.0/ | spa |
oaire.fundername | Colombia. Ministerio de Ciencia, Tecnología e Innovación - MinCiencias | spa |
oaire.fundername | DFG, German Research Foundation | spa |
oaire.fundername | German Rheumatism Research Centre | spa |
oaire.fundername | Federal Ministry of Education and Research | spa |
dc.publisher.place | Lausana, Suiza | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/ART | spa |
dc.type.local | Artículo de investigación | spa |
dc.subject.decs | Agammaglobulinemia Tirosina Quinasa - inmunología | - |
dc.subject.decs | Agammaglobulinaemia Tyrosine Kinase - immunology | - |
dc.subject.decs | Enfermedades Autoinmunes | - |
dc.subject.decs | Autoimmune Diseases | - |
dc.subject.decs | Linfocitos B | - |
dc.subject.decs | B-Lymphocytes | - |
dc.subject.decs | Proteínas Tirosina Fosfatasas - inmunología | - |
dc.subject.decs | Protein Tyrosine Phosphatases - immunology | - |
dc.subject.decs | Receptores de Antígenos de Linfocitos B - inmunología | - |
dc.subject.decs | Receptors, Antigen, B-Cell - immunology | - |
dc.subject.decs | Quinasa Syk - inmunología | - |
dc.subject.decs | Syk Kinase - immunology | - |
dc.subject.decs | Lupus Eritematoso Sistémico | - |
dc.subject.decs | Lupus Erythematosus, Systemic | - |
dc.subject.decs | Antígenos CD40 | - |
dc.subject.decs | CD40 Antigens | - |
dc.subject.decs | Receptor Toll-Like 9 | - |
dc.subject.decs | Toll-Like Receptor 9 | - |
dc.description.researchgroupid | COL0008639 | spa |
oaire.awardnumber | MinCiencias 727, 2015 | spa |
oaire.awardnumber | (project Do491/10- 1, TR130, SFB650, CRC Immunobone) | spa |
oaire.awardnumber | BMBF 031L0101D | spa |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D000077329 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D001327 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D001402 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D017027 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D011947 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D000072377 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D008180 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D019013 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D051217 | - |
dc.relation.ispartofjournalabbrev | Front. Immunol. | spa |
oaire.funderidentifier.ror | RoR:03fd5ne08 | - |
oaire.funderidentifier.ror | RoR:018mejw64 | - |
oaire.funderidentifier.ror | RoR:00shv0x82 | - |
oaire.funderidentifier.ror | RoR:04pz7b180 | - |
Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
RiconHector_2019_Identification_Characterization_Bcell.pdf | Atículo de investigación | 2.03 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons